+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Atypical beta-adrenoceptors, different from beta-3-adrenoceptors, mediate the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat

Atypical beta-adrenoceptors, different from beta-3-adrenoceptors, mediate the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat

Polish Journal of Pharmacology 47(Suppl. ): 38-39

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 030223968

Download citation: RISBibTeXText

Related references

Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors. British Journal of Pharmacology 117(5): 943-949, 1996

The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms. Journal of Pharmacology and Experimental Therapeutics 263(3): 1083-1090, 1992

Positive chronotropic activity of angiotensin II in the pithed normotensive rat is primarily due to activation of cardiac beta 1-adrenoceptors. Naunyn-Schmiedeberg's Archives of Pharmacology 338(2): 185-190, 1988

Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat. British Journal of Pharmacology 122(7): 1307-1314, 1997

(+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig. Naunyn-Schmiedeberg's Archives of Pharmacology 317(4): 277-285, 1981

Interaction of dihydroalprenolol and cyanopindolol with atypical beta adrenoceptors in guinea pig ileum. British Journal of Pharmacology 96(Suppl.): 246P, 1989

Xamoterol activates beta 1 but not beta 2 adrenoceptors in mammalian myocardium comparison of its affinity for beta 1 and beta 2 adrenoceptors coupled to the adenylate cyclase in feline and human ventricle with positive inotropic effects. Journal of Cardiovascular Pharmacology 13(1): 105-117, 1989

-Cyanopindolol binds to a site resembling atypical beta-adrenoceptors in gastrointestinal tissues. British Journal of Pharmacology 112(PROC Suppl. MAY): 212P, 1994

The action of cyanopindolol at atypical beta adrenoceptors in rat gastric fundus and distal colon in vitro. Szabadi, E And C M Bradshaw (Ed ) Advances in Pharmacological Sciences: Adrenoceptors: Structure, Mechanisms, Function; Third Manchester Symposium on The Pharmacology Of Adrenoceptors Held As A Satellite Symposium to The Amsterdam Iuphar Congress, Manchester, England, Uk, June 1990 Xvi+376p Birkhaeuser Verlag: Basel, Switzerland; Boston, Massachusetts, Usa Illus 357-358, 1991

Atypical beta-adrenoceptors, different from beta3-adrenoceptors and probably from the low-affinity state of beta1-adrenoceptors, relax the rat isolated mesenteric artery. British Journal of Pharmacology 140(1): 3-12, 2003

Beta 2 adrenoceptors predominate in mouse trachea but beta 1 adrenoceptors mediate relaxation of the smooth muscle. American Review of Respiratory Disease 139(4 Part 2): A258, 1989

Interaction of selected inotropic agents with alpha adrenoceptors and beta adrenoceptors in pithed rat. Federation Proceedings 43(4): ABSTRACT 4446, 1984

Indications for vascular alpha 2 adrenoceptors and beta 2 adrenoceptors in synapses of the muscarinic pathway in the pithed normotensive rat. Journal of Pharmacology & Experimental Therapeutics 223(1): 219-223, 1982

Evidence for the existence of 'atypical' beta-adrenoceptors (beta 3-adrenoceptors) mediating relaxation in the rat distal colon in vitro. British Journal of Pharmacology 101(3): 569-574, 1990

Evidence for a noradrenergic innervation to "atypical" beta adrenoceptors (or putative beta-3 adrenoceptors) in the ileum of guinea pig. Journal of Pharmacology and Experimental Therapeutics 260(1): 192-200, 1992